February 28, 2022
Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat in Patients with Alzheimer’s Disease
Vivoryon Therapeutics a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines and Simcere Pharmaceutical Group have announced that…